UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selection of a trioxaquine as an antimalarial drug candidate

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (45), p.17579-17584

2008

Volltextzugriff (PDF)

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Structure and stereochemistry of the active metabolite of clopidogrel

Drug metabolism and disposition, 2002-11, Vol.30 (11), p.1288-1295

2002

Volltextzugriff (PDF)

The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor

The Journal of biological chemistry, 1998-10, Vol.273 (41), p.26273-26276

1998

Volltextzugriff (PDF)

The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today?

Comptes rendus. Chimie, 2012-08, Vol.15 (8), p.737-743

Maffrand, Jean-Pierre

2012

Volltextzugriff (PDF)

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.1122

2002

Volltextzugriff (PDF)

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

British journal of pharmacology, 1998-12, Vol.125 (7), p.1393-1395

1998

Volltextzugriff (PDF)

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Volltextzugriff (PDF)

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Hepatology (Baltimore, Md.), 2007-07, Vol.46 (1), p.122-129

2007

Volltextzugriff (PDF)

SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor

The Journal of pharmacology and experimental therapeutics, 2004-04, Vol.309 (1), p.414

2004

Volltextzugriff (PDF)

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum

Drug metabolism and disposition, 2006-04, Vol.34 (4), p.667-682

2006

Volltextzugriff (PDF)

New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists: Identification of Ethyl 3-[N-[4-[4-[Amino[(ethoxycarbonyl)imino]methyl]phenyl]- 1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent

Journal of medicinal chemistry, 1997-10, Vol.40 (21), p.3393-3401

1997

Volltextzugriff (PDF)

Role of tachykinins in castor oil diarrhoea in rats

British journal of pharmacology, 1997-06, Vol.121 (3), p.375-380

1997

Volltextzugriff (PDF)

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

FEBS letters, 2000-06, Vol.475 (2), p.150-156

2000

Volltextzugriff (PDF)

Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries

Circulation (New York, N.Y.), 2001-11, Vol.104 (19), p.2331-2337

2001

Volltextzugriff (PDF)

In vitro characterization of tachykinin NK2‐receptors modulating motor responses of human colonic muscle strips

British journal of pharmacology, 1998-07, Vol.124 (6), p.1321-1327

1998

Volltextzugriff (PDF)

La chimie et la santé: Au service de l'homme

Jean-François Bach, Mireille Blanchard-Desce, Patrick Couvreur, Frédéric Dardel, Carine Giovannangeli, Jean-Pierre Maffrand, Daniel Mansuy, Bernard Meunier, Marc Port / Minh-Thu Dinh-Audouin, Danièle Olivier, Paul Rigny, Agnès Rose Jacquesy

2010

Volltextzugriff (PDF)

Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidus

Nephrology, dialysis, transplantation, 2001-04, Vol.16 (4), p.725-734

2001

Volltextzugriff (PDF)

The Neuroprotective Agent SR 57746A Abrogates Experimental Autoimmune Encephalomyelitis and Impairs Associated Blood-Brain Barrier Disruption: Implications for Multiple Sclerosis Treatment

Proceedings of the National Academy of Sciences - PNAS, 1999-10, Vol.96 (22), p.12855-12859

1999

Volltextzugriff (PDF)

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors

European journal of pharmacology, 2002-08, Vol.450 (1), p.77-83

2002

Volltextzugriff (PDF)

Peripheral biological activity of SR 27897 : a new potent non-peptide antagonist of CCKA receptors

European journal of pharmacology, 1993-02, Vol.232 (1), p.13-19

1993

Volltextzugriff (PDF)

SR 121787, a new orally active fibrinogen receptor antagonist

Thrombosis and haemostasis, 1998-09, Vol.80 (3), p.469-476

1998

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1997-02, Vol.280 (2), p.802

1997

Volltextzugriff (PDF)

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

Proceedings of the National Academy of Sciences - PNAS, 1993-01, Vol.90 (1), p.65-69

1993

Volltextzugriff (PDF)

In vitro functional evidence of different neurotensin‐receptors modulating the motor response of human colonic muscle strips

British journal of pharmacology, 1999-08, Vol.127 (8), p.1922-1928

1999

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selection of a trioxaquine as an antimalarial drug candidate

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Structure and stereochemistry of the active metabolite of clopidogrel

The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor

The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today?

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum

New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists: Identification of Ethyl 3-[N-[4-[4-[Amino[(ethoxycarbonyl)imino]methyl]phenyl]- 1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent

Role of tachykinins in castor oil diarrhoea in rats

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries

In vitro characterization of tachykinin NK2‐receptors modulating motor responses of human colonic muscle strips

La chimie et la santé: Au service de l'homme

Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidus

The Neuroprotective Agent SR 57746A Abrogates Experimental Autoimmune Encephalomyelitis and Impairs Associated Blood-Brain Barrier Disruption: Implications for Multiple Sclerosis Treatment

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors

Peripheral biological activity of SR 27897 : a new potent non-peptide antagonist of CCKA receptors

SR 121787, a new orally active fibrinogen receptor antagonist

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

In vitro functional evidence of different neurotensin‐receptors modulating the motor response of human colonic muscle strips

Suchergebnisse filtern